BioSpace News Archive

CVS Health Corporation announced that Karen Lynch, Executive Vice President and Chief Executive Officer, will participate in a fireside chat with investors at the Goldman Sachs 42nd Annual Healthcare Conference on June 9, 2020, at approximately 10:30 am EST.

The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is pleased to announce the appointment of three new members to its Board of Directors.

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

The Government of Canada is working with all partners to protect the health and safety of Canadians and to reduce the spread of COVID-19 and the variants of concern in Canada.

Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today that its application for Marketing Authorization (MA) for Endari® in the Kingdom of Saudi Arabia has been accepted by the Saudi Food and Drug Authority (SFDA)

Dr. Nagdev, Director of Emergency Ultrasound at Highland Hospital, has been a leading voice for point-of-care ultrasound use in emergency medicine

BiologyWorks™, a medical test developer with a mission to deliver fast and accurate molecular testing, launches its innovative and affordable BiologyWorks k™ test.

(Euronext – FR0010557264 – AB) communicated the results from phase 3 study evaluating masitinib in prostate cancer during the webcast that was held on May 25, 2021.

Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company currently focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer and blood disorders, invites investors to review the Company’s shareholder update conference call presentation via its website,

New analysis suggests the California variant is more transmissible than unmutated strains, but vaccines are effective against it